Advanced Biomed Inc. Common Stock (ADVB) Revenue History
Annual and quarterly revenue from 2021 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ADVB Revenue Growth
ADVB Revenue Analysis (2021–2025)
As of May 9, 2026, Advanced Biomed Inc. Common Stock (ADVB) generated trailing twelve-month (TTM) revenue of $17,200. The most recent quarter (Q1 2026) recorded $0 in revenue, down 100.0% sequentially.
Looking at the longer-term picture, ADVB's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including AGEN (+10.4% YoY), KROS (+6775.0% YoY), and TGTX (+81.3% YoY). Compare ADVB vs AGEN →
ADVB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ADVBCurrent | $17,200 | - | - | - | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 KROS | $244M | +6775.0% | - | 28.9% | |
 TGTX | $616M | +81.3% | +426.7% | 20.0% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% |
ADVB Historical Revenue Data (2021–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-10,711 | - | $-94,112 | - |
| 2024 | $0 | - | $-12,550 | - | $-2,541,572 | - |
| 2023 | $0 | - | $-11,888 | - | $-3,071,223 | - |
| 2022 | $0 | - | $-4,477 | - | $-2,374,371 | - |
| 2021 | $0 | - | $-2,031 | - | $-1,836,940 | - |
See ADVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADVB — Frequently Asked Questions
Quick answers to the most common questions about buying ADVB stock.
Is ADVB's revenue growth accelerating or slowing?
ADVB TTM revenue: $17200.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ADVB's long-term revenue growth rate?
Advanced Biomed Inc. Common Stock's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ADVB's revenue distributed by segment?
ADVB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2021-2025 are available for download. Segment mix reveals concentration and diversification trends.